Topic: Pharma Labels

12Sep/18

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

After marquee HIV drug approvals last year for Gilead and GlaxoSmithKline, Merck will follow into the crowded market with two new meds. The drugmaker scored FDA approvals for a new non-nucleoside reverse transcriptase inhibitor calledRead More…

11Jul/18

Mylan Launches Generic Version Of The Novartis Exelon Patch

Mylan N.V. today announced the U.S. launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon Patch. Mylan received final approval fromRead More…

11Aug/13

FDA May Soon Allow Generic Drug Makers to Update Safety Information On Pharmaceutical Labels

A Pharmaceutical Label Can Be Updated Sooner by Marie Ellis of Medical News Today Present Food and Drug Administration (FDA) regulations prohibit generic drug manufacturers from updating a product’s safety on theRead More…